Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS)

Q1 2022 13F Holders as of 3/31/2022

Type / Class: Equity / Common Stock, $0.00001 par value
Number of holders: 105
Total Shares: 59.1M
Shares change: +3.53M
Total reported value, excl. options: $1.02B
Value change: +$65.5M
Put/Call ratio: 0.9
Number of buys: 44
Number of sells: -68
Price: $17.24

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.